Mark Krystal
12Patents
5h-index
24Co-inventors
66Inventor score
Filing activity: May 22, 1990 → Aug 7, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5166057A | Recombinant negative strand RNA virus expression-systems | Chemistry; Metallurgy | 214 | Expired |
| US5578473A | Recombinant negative strand RNA virus | Chemistry; Metallurgy | 47 | Expired |
| US5837852A | Capped nucleic acid oligomers that inhibit cap-dependent transcription of the influenza virus endonuclease | Chemistry; Metallurgy | 18 | Expired |
| US7176196B2 | Bicyclic heterocycles as HIV integrase inhibitors | Human Necessities | 15 | Expired |
| US7157447B2 | Bicyclic heterocycles as HIV integrase inhibitors | Human Necessities | 11 | Expired |
| US7276356B1 | Recombinant negative strand RNA virus expression systems and vaccines | Emerging Cross-Sectional Technologies | 4 | Expired |
| US7030140B2 | Substituted benzimidazole antiviral agents | Chemistry; Metallurgy | 4 | Expired |
| US5691189A | Saccharomyces cerevisiae expressing M.sub.2 protein of influenza A virus | Chemistry; Metallurgy | 4 | Expired |
| US7511037B2 | N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor | Human Necessities | 3 | Active |
| US6908936B2 | Substituted benzimidazole antiviral agents | Chemistry; Metallurgy | 0 | Expired |
| US10407490B2 | Polypeptides targeting HIV fusion | Chemistry; Metallurgy | 0 | Active |
| US11155602B2 | Polypeptides targeting HIV fusion | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.